Authors/Disclosures
|
Youngbin Choi, MD
(Multicare)
|
No disclosure on file |
|
Maher Saqqur, MD
(University of Alberta)
|
Dr. Saqqur has nothing to disclose. |
|
Dobri Baldaranov, MD
(ATRI Keck School of Medicine)
|
No disclosure on file |
|
Ali Al-Khathaami, MD
(King Abdulaziz Medical City)
|
No disclosure on file |
|
|
No disclosure on file |
|
Richard T. Moxley III, MD, FAAN
|
Dr. Moxley has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Jean-Martin Boulanger, MD, FRCPC
(Jean Martin Boulanger)
|
No disclosure on file |
|
Andrew M. Demchuk, MD
(Foothills Hospital/Calgary Stroke Program)
|
Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lumosa. Dr. Demchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer/BMS. Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Demchuk has received stock or an ownership interest from Circle NVI. Dr. Demchuk has received intellectual property interests from a discovery or technology relating to health care. |